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a b s t r a c t
Evolutionary analyses have revealed that most host-encoded restriction factors against HIV have
experienced virus-driven selection during primate evolution. However, HIV also depends on the function
of many human proteins, called host factors, for its replication. It is not clear whether virus-driven
selection shapes the evolution of host factor genes to the extent that it is known to shape restriction
factor genes. We show that ﬁve out of 40 HIV host factor genes (13%) analyzed do bear strong signatures
of positive selection. Some of these genes (CD4, NUP153, RANBP2/NUP358) have been characterized with
respect to the HIV lifecycle, while others (ANKRD30A/NY-BR-1 and MAP4) remain relatively uncharacter-
ized. One of these, ANKRD30A, shows the most rapid evolution within this set of genes and is induced by
interferon stimulation. We discuss how evolutionary analysis can aid the study of host factors for viral
replication, just as it has the study of host immunity systems.
& 2014 Elsevier Inc. All rights reserved.
Introduction
HIV exploits a vast network of human proteins in order to
replicate inside of human cells. These human proteins, referred
to here as HIV host factors, are involved in processes such as
transcription, translation, and transport of the virus (Friedrich
et al., 2011; Goff, 2007). Experimentally, the depletion or disabling
of HIV host factors decreases viral replication. For this reason,
these host proteins constitute novel and potentially highly effec-
tive antiviral drug targets. For example, the FDA has approved the
ﬁrst anti-HIV drug targeting such a protein, Maraviroc, which is a
small molecule antagonist of the HIV co-receptor CCR5. For this
reason, there is intense interest in identifying the human proteins
that promote the replication of viruses that cause human disease,
including HIV, inﬂuenza, West Nile virus, Dengue virus, and others
(reviewed in (Fernandez-Garcia et al., 2009; Friedel and Haas,
2011; Hirsch, 2010; Houzet and Jeang, 2011; Hsu and Spindler,
2012; Shaw, 2011; Telenti and Johnson, 2012; Watanabe et al.,
2010)).
In several genetic screens aimed at identifying HIV host factors,
RNA interference was used to systematically deplete human gene
transcripts, and then the effects of depletion on HIV replication
were evaluated (reviewed in (Bushman et al., 2009; Goff, 2008)).
Collectively, these screens uncovered approximately a thousand
genes that lead to reduced HIV replication when their expression
is decreased (Brass et al., 2008; König et al., 2008; Yeung et al.,
2009; Zhou et al., 2008). Another proteomics-based study recently
employed afﬁnity puriﬁcation and mass spectrometry to uncover
435 human proteins that interact with HIV proteins (Jäger et al.,
2012). While these high-throughput technologies have undoubt-
edly led to new insights, one surprise has been the low overlap of
candidates generated between the different screens, and between
the screens and the interactions previously reported in the
literature (Bushman et al., 2009; Jäger et al., 2012). Similar
scenarios have played out in other ﬁelds of virology where high-
throughput studies are being employed (de Chassey et al., 2012;
Friedel and Haas, 2011). While there are certainly many important
new host factor genes being identiﬁed, the task now at hand is to
triage these gene lists for further, more in depth mechanistic
studies.
Advantageous mutations are preferentially inherited in popula-
tions due to the forces of positive natural selection. Repeated
rounds of positive selection have been faithfully detected in all
well-characterized HIV restriction factor genes (TRIM5, APOBECs,
Tetherin, and SAMHD1) (Compton et al., 2012; Gupta et al., 2009;
Laguette et al., 2012; Lim et al., 2010, 2012; McNatt et al., 2009;
OhAinle et al., 2006; Sawyer et al., 2004, 2005). This evolutionary
signature results from the millions-of-years long struggle for
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survival between retroviruses and the primates that they infect
(Compton and Emerman, 2013; Gifford, 2012; Stoye, 2012).
Restriction factors block the replication of HIV upon recognition
of and interaction with speciﬁc viral targets (Malim and Bieniasz,
2012). Retroviruses, in turn, often encode antagonist proteins that
speciﬁcally recognize and inhibit restriction factor proteins (Malim
and Emerman, 2008). The evolutionary battles between restriction
factors and viruses play out at physical interaction interfaces
between host and virus proteins. Both parties (host and virus)
are continuously selected for mutations that modulate this inter-
action. For instance, the gene encoding the TRIM5α restriction
factor has experienced continuous positive selection for mutations
that allow TRIM5α to better recognize its target, the retroviral
capsid (Sawyer et al., 2005), while capsid continuously evolves to
escape interaction with TRIM5α (Kirmaier et al., 2010; McCarthy
et al., 2013). This continual evolutionary struggle is referred to as
an evolutionary “arms race” and, because it plays out at the level
of protein–protein interactions, results in the rapid evolution of
each of the interacting host and viral proteins (Meyerson and
Sawyer, 2011). This signature of rapid evolution is so typical of
restriction factors that it has even been used to predict novel
virus-binding domains of restriction factors (Daugherty and Malik,
2012).
Host factor genes may also have the potential to undergo
positive selection for new allelic forms. In fact, we recently showed
that the TFR1 gene, which encodes a receptor used by several
viruses for cellular entry, has undergone multiple rounds of
positive selection (Demogines et al., 2013; Kaelber et al., 2012).
In the case of host factors, host genomes will experience selection
for alleles that reduce interactions with viruses. However, there
are two critical differences between restriction factor and host
factor genes. First, gain-of-function alleles of restriction factor
genes are expected to have a dominant effect on viral replication.
In contrast, loss-of-function alleles of host factor genes are
expected to have a recessive or, at best, semi-dominant effect on
viral replication because there is another allele to supply the host
factor required by HIV. Second, it is not known whether HIV host
factor genes have the functional ﬂexibility to evolve under positive
selection like restriction factors. Unlike restriction factors which
are typically dedicated proteins of the innate immune system
(Blanco-Melo et al., 2012), host factors have important roles in
cellular physiology and are expected to have signiﬁcantly more
evolutionary constraint acting upon them.
Results
To address the question of whether or not HIV host factors also
experience positive selection, we looked at the evolution of genes
recently identiﬁed in several genome-wide RNA interference
screens for HIV-1 host factors (Brass et al., 2008; König et al.,
2008; Yeung et al., 2009; Zhou et al., 2008). Speciﬁcally, we focused
on the 40 human genes that were identiﬁed in two or more of these
screens (Fig. 1A) (Bushman et al., 2009; Yeung et al., 2009). For each,
we calculated the dN/dS ratio, which summarizes the rate at which
non-synonymous (amino-acid altering; dN) and synonymous
(silent; dS) mutations have accumulated in a gene over evolutionary
time. Repeated rounds of positive natural selection for non-
synonymous mutations results in dN/dS41, whereas conservation
of protein-coding sequence results in dN/dSo1 (Goldman and
Yang, 1994). We gathered sequences for each of these 40 genes
from the human, chimpanzee, and rhesus macaque genome pro-
jects, and generated a 3-species multiple alignment for each gene.
One of the 40 genes, RGPD8, was excluded because it is a recent
duplication of another gene on this list, RANBP2, and could not be
clearly identiﬁed in other primate genomes (Ciccarelli, 2005).
We ﬁnd that the remaining 39 host factor genes generally have
lower whole-gene dN/dS values than genes encoding restriction
factors (Fig. 1B), consistent with previous reports (Ortiz et al., 2009)
and with their important roles as housekeeping genes.
Next, we gathered additional sequence from two other avail-
able primate genome projects (Sumatran orangutan and common
marmoset), and used three different sequence pairs for each gene
to calculate dN/dS in sliding windows along the length of each
gene (Parmley and Hurst, 2007). Rather than just averaging dN/dS
across a gene, this analysis can highlight domains of dN/dS41. The
analyses of two genes, CXCR4 and CD4, illustrate how sliding
window analysis can reveal conservation (CXCR4) or positive
selection (CD4), despite the small number of sequences going into
the analysis (Fig. 1C). Sliding window analysis has an inherent
multiple testing problem that is difﬁcult to correct (Schmid and
Yang, 2008). As an ad hoc method for reducing false positive
signatures, we sought genes with regions of dN/dS signiﬁcantly
41 in at least two out of three pairwise primate comparisons
made. We ﬁnd that eight out of 39 genes meet this criterion
(highlighted in Fig. 1D).
To verify these signatures of positive selection in a more
statistically robust fashion, we next generated large primate
datasets for each of these eight candidate genes. Each gene was
sequenced from 15 simian primate species and these sequences
were combined with those gathered from the ﬁve genome projects
mentioned above (the 20 species included in this dataset are
indicated with asterisks in Fig. 2). In all, 153 gene sequences were
generated for the eight genes of interest.
The multiple sequence alignment generated for each gene was
analyzed for positive selection with PAML (Yang, 1997). Alignments
were ﬁt to a neutral model (Model M8a) where all codon positions are
constrained to evolve with dN/dSr1, and a positive selection model
(Model M8) where a dN/dS41 category of codons is allowed. A
likelihood ratio test was then used to compare the positive selection
model to the neutral model. The neutral model is rejected (po0.005)
in favor of the positive selection model in ﬁve of the eight datasets
analyzed: ANKRD30A, CD4, MAP4, NUP153, and RANBP2 (Table 1).
As expected, amino acids encoded by codons in the dN/dS41 class
are highly variable between species (Fig. 2). We next acquired blood
or tissue for small population groups representing seven different
primate species, and we investigated human polymorphism using the
1000 Genomes and dbSNP databases. As has been found in restriction
factor genes (Meyerson and Sawyer, 2011), we identiﬁed polymorph-
ism at several codon positions under positive selection, as illustrated
for ANKRD30A and MAP4 (Fig. 2). This suggests that the functions of
these genes could be variable between individuals in a species, as has
been shown for other host factors and restriction factors (Duggal et al.,
2013; Kirmaier et al., 2010; O'Brien and Nelson, 2004). In ANKRD30A,
we ﬁnd SNPs at one site of positive selection (codon/residue 1037) in
both human and rhesus macaque populations. We were unable to
sequence ANKRD30A from owl monkeys. Unlike all other genes
analyzed herein, the inability to sequence ANKRD30A from some
species was a consistent problem in our study (Table 1). This may
suggest that this gene is being lost, duplicated, or rearranged in
different species. This gene has also been identiﬁed as copy number
variable in the human population (Park et al., 2010), and gene dosage
of a host factor could theoretically contribute to variable HIV suscept-
ibility and/or disease progression.
Of the ﬁve genes under positive selection, all except ANKRD30A
have established roles in the HIV lifecycle. CD4 is the primary
receptor for primate immunodeﬁciency viruses, including HIV-1.
In concordance with the ﬁndings of a previous study of CD4,
signatures of positive selection are concentrated in the D1 domain
of CD4 (Zhang et al., 2008), coinciding with the known binding
region with HIV gp120 (Kwong et al., 1998). Ten of the 13 sites
identiﬁed in our evolutionary analysis of CD4 fall in this region.
N.R. Meyerson et al. / Virology 454-455 (2014) 291–298292
NUP153 and RANBP2, both associated with the nuclear pore,
are known to be important for the trafﬁcking of pre-integration
complexes into the nucleus (Di Nunzio et al., 2012; Matreyek and
Engelman, 2011; Woodward et al., 2009; Schaller et al., 2011). The
C-terminal cyclophilin domain in RANBP2 directly interacts with
HIV capsid (Schaller et al., 2011), and three residues in this
cyclophilin domain are under positive selection (T3153, Q3163,
and K3177). NUP153 has been shown to interact with both
integrase and capsid via its C-terminal FXFG hydrophobic repeat
domain (Matreyek et al., 2013; Woodward et al., 2009) in which
we have identiﬁed residue V1189 to be evolving under positive
selection. Recently, a role for the microtubule-associated protein
MAP4 was reported (Gallo and Hope, 2012). Depletion of MAP4
was shown to impact HIV-1 reverse transcription but not nuclear
translocation. It is currently unknown whether or not MAP4
directly interacts with viral proteins, and if so, whether or not
this interaction surface is correlated to the sites in MAP4 that we
have identiﬁed to be evolving under positive selection.
No role for ANKRD30A in HIV biology has yet been reported.
Interestingly, ANKRD30A has the highest dN/dS value of any HIV
host factor in our study (Fig. 1B and 2Δl value shown in Table 1).
ANKRD30A was identiﬁed in two genome-wide RNAi screens
conducted in HeLa cells (Brass et al., 2008; Zhou et al., 2008),
but not in similar screens performed in 293T or Jurkat cells (König
et al., 2008; Yeung et al., 2009). It was also not identiﬁed in a
proteomic screen for HIV-interacting proteins which was con-
ducted in both 293 and Jurkat cells (Jäger et al., 2012). In order
to investigate this discrepancy, we tested the expression of
ANKRD30A in a human cDNA panel, HeLa, 293T, and Jurkat cells.
Using a human cDNA panel, we ﬁnd that ANKRD30A is expressed
in several human tissues (Fig. 3A). A close paralog of this gene,
ANKRD30B, is also expressed widely but in different tissues (see
Fig. S3 in Supplemental material). Interestingly, we ﬁnd that
ANKRD30A is not expressed in any of the cell lines used in the
RNAi screens (Fig. 3B), making it hard to understand why this gene
would have been identiﬁed in any screens. The transfection of
short interfering RNAs (siRNAs), which was performed in several
of these screens, is known to induce the interferon response
(Whitehead et al., 2011). It is thought that siRNAs are detected
by pattern recognition receptors in the cytoplasm, which then
initiate the interferon production cascade. To see if ANKRD30A is
induced by interferon, we treated HeLa, 293T, and Jurkat cells with
1000 U/ml interferon-β and found that expression of ANKRD30A is
readily detected in HeLa and Jurkat cells, but not in 293T cells
(Fig. 3B). These expression patterns may explain why ANKRD30A
was found only in screens that combined HeLa cells with siRNA
transfection (Fig. 3C). Under these conditions ANKRD30A expres-
sion would have been induced and then knocked-down only with
Fig. 1. Evolutionary analysis of genes encoding HIV host factors. (A) Each circle represents a whole-genome RNA interference screen previously conducted to identify human
genes important for HIV replication (Brass et al., 2008; König et al., 2008; Yeung et al., 2009; Zhou et al., 2008). Indicated within overlap regions are the numbers of human
genes identiﬁed in multiple screens. (B) A histogram shows whole-gene dN/dS values previously calculated for 10,376 orthologous gene trios from the human, chimpanzee,
and rhesus genomes (Rhesus Macaque Genome Sequencing and Analysis Consortium et al., 2007). On the x-axis is the average dN/dS calculated over the length of each gene
for this three-species tree. On the y-axis is the number of gene trios with the average dN/dS value. On this distribution are overlayed the dN/dS values for similar trios hand-
curated for known HIV restriction factors (red asterisks), and for the 39 putative host factors analyzed in this study (gray asterisks). dN/dS values were calculated using the
M0 model in PAML (Yang, 1997). The restriction factors are (from left to right on the distribution): SAMHD1, Tetherin, ZAP, TRIM22, TRIM5, APOBEC3H, APOBEC3DE, APOBEC3G.
(C) Example sliding window analyses for CXCR4 and CD4. The x-axis is in base pairs and represents the length of each gene. dN/dS was calculated in sliding windows moving
along the length of the gene. The three pairwise species comparisons made are color-coded (blue, human vs. orangutan; red, human vs. rhesus; green, rhesus vs. marmoset).
For each comparison, the window with the highest dN/dS value was tested for statistical signiﬁcance using a Monte Carlo simulation (Comeron, 1999), and two windows
where dN/dS is signiﬁcantly greater than 1 (po0.001 and po0.004) are indicated. (D) The maximum dN/dS value observed in each pairwise sliding window analysis is
summarized. An asterisk (*) indicates instances where dN/dS is signiﬁcantly greater than 1 (po0.05).
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on-target interfering RNAs. Jurkat cells are not easily transfectable,
so in screens that employed these cells, transduction was used
instead. This is an example of how genome-wide screens may be
sensitive to the particular cell type used, and why different screens
might identify different genes.
Discussion
In summary, we have identiﬁed ﬁve human genes that both
promote HIV replication and contain signatures of positive selection.
Ancient lentiviruses may have provided the selective pressure that
drove the positive selection of these genes, based on the following
observations. First, four out of ﬁve of the genes under positive
selection have conﬁrmed roles in the lifecycle of HIV/SIV. Second, in
the three genes that have been shown to encode HIV-interacting
proteins, codons under positive selection map to known HIV-
interaction domains. While these observations support the notion
that ancient lentiviruses may have driven the positive selection of
these genes, further experimental validation is needed to fortify this
conclusion. For example, if lentiviruses drove this selection then
mutations made speciﬁcally at sites under positive selection should
alter interactions with one or more lentiviruses. Several studies have
demonstrated this for restriction factors, where substitutions of
naturally-occurring amino acids at sites under positive selection
drastically alter patterns of restriction (Compton and Emerman,
2013; Lim et al., 2010; Sawyer et al., 2005). Also, we have previously
demonstrated this for TFR1, a host factor that promotes the replication
of retroviruses, arenaviruses, and parvoviruses (Demogines et al., 2013;
Kaelber et al., 2012). Although one site under positive selection in CD4
has been shown to alter the speciﬁcity of HIV entry (Humes et al.,
2012), the other sites that we have identiﬁed are uncharacterized with
respect to their role in lentiviral glycoprotein binding. Similarly, with
ANKRD30A, MAP4, NUP153, and RANBP2, it remains to be determined
what role, if any, sites under positive selection in primate datasets play
in determining speciﬁc interactions with lentiviruses. Mutation of a
positively selected residue in RANBP2 was shown to affect its inter-
action with HIV capsid, although this site was identiﬁed in a more
extensive mammalian dataset (Schaller et al., 2011).
We cannot rule out the possibility that these host genes have
evolved under selection imposed by other pathogens. Indeed,
NUP153 has been shown to also mediate inﬂuenza replication in
an RNA interference screen (König et al., 2010), and it is well
documented that many nuclear-replicating viruses interact with
the nuclear pore (Cohen et al., 2011). Also, proteins like MAP4 that
are involved in intracellular trafﬁcking have also been shown to be
a common target of viral hijacking (Radtke et al., 2006). We
conclude that positive selection can shape the evolution of host
factor genes, consistent with other recent studies on cell surface
receptors (Demogines et al., 2013; Kaelber et al., 2012; Martin
et al., 2013), components of the nuclear pore (Schaller et al., 2011),
and DNA repair machinery (Demogines et al., 2010; Sawyer and
Malik, 2006).
We have previously demonstrated that mutations in one host
factor for viral replication, the TfR1 receptor, reduce interactions with
virions and act in a semi-dominant fashion to limit virus entry
Fig. 2. ANKRD30A and MAP4 exhibit signatures of positive selection. A cladogram illustrates the relationship of the primate species analyzed in this study. The 20 species
used in the positive selection analysis are indicated with an asterisk next to the species name. Numbers at the top refer to codon coordinates in two genes, ANKRD30A and
MAP4. These four codons shown were identiﬁed as evolving under positive selection, and as expected the amino acids encoded at these sites are highly variable between
species. The arbitrarily colored boxes represent different amino acids encoded. All codons under positive selection in ANKRD30A and MAP4 were sequenced from individuals
representing small population sets of different primate species (indicated with a triangle at the end of the branch on the primate cladogram). For humans, SNPs were
identiﬁed in human SNP databases. Non-synonymous SNPs identiﬁed are indicated by two squares next to each other. A hyphen indicates lack of information, because
ANKDR30A could not be sequenced from these species. These four codons were chosen for illustration because they are under positive selection and also bear SNPs in human
or primate populations.
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(Demogines et al., 2013). This is because, in heterozygotes, half of the
receptor pool is affected. In this way, selection can operate on loss-of-
function alleles in host factor genes even in heterozygous individuals
(Meyerson and Sawyer, 2011). Selection might be expected to be less
intense on a semi-dominant trait than on a dominant trait. This is
consistent with our ﬁnding that host factor genes are generally more
conserved than restriction factor genes (Fig. 1B), and that many host
factor genes analyzed did not experience positive selection at all.
Indeed, CXCR4, LEDGF and CPSF6 are examples of human genes
that are well-known to be involved in HIV replication, but that are
extremely conserved in protein sequence (Cherepanov, 2004; Lee
et al., 2012).
More extensive work will be needed to characterize the role of
ANKRD30A as a host factor for HIV-1, and to investigate a possible
Table 1
PAML analysis of genes encoding HIV host factors.
Genea Number
of speciesa
2Δlb p-Valueb Positive
selection?
dN/dSc % Sitesc Codons with dN/dS41d
ANKRD30A, aa 973–1335 13 36 o0.001 yes 3.5 34% A985, D986n, Q1015nn, I1022n, V1027, N1032, T1037,
C1049nn, A1063n, S1100, Q1107n, I1169nn, C1174nn, E1191,
L1211n, R1233nn, M1239, F1268n, H1285, H1299n, E1302, L1309
CD4, aa 28–424 25 15 o0.001 yes 2.2 18% T15, T17n, Q20n, S23n, N32, I34, N39n, N52n, A55n, D88n, K206n,
W214, R240n
IBTK, aa 1–1353 20 0.9 0.340 no na na na
MAP4, aa 10–1152 20 8.2 o0.005 yes 5.5 1.0% L566, T631, E640nn, A814
NUP98/96, aa 80–1636 20 0.5 0.464 no na na na
NUP153, aa 1–1475 20 8.9 o0.003 yes 6.4 0.5% I794, V1189nn
RANBP2, aa 2002–3224 20 15 o0.001 yes 3.7 2.2% H2418nn, A2724n, M2786n, M2813n, A2890n, T3153,
Q3163, K3177n
WNK1, aa 742–2073 20 0.07 0.795 no na na na
a Each dataset consists of gene orthologs from 20 primate species, with two exceptions. ANKRD30A could not be ampliﬁed from seven primate species so the ﬁnal dataset
consisted of only 13 species. In the case of CD4, sequences from ﬁve additional primate species beyond the core set of 20 species were available on Genbank. Two of the
genes, ANKRD30A and RANBP2, were difﬁcult to amplify from the available primate tissues, so we focused on sequencing the portion of these genes corresponding to the
location of dN/dS41 peaks in the sliding window analysis. The gene regions analyzed are indicated (by encoded amino acids, aa).
b Twice the difference in the natural logs of the likelihoods (2Δl) of the two models (M8a-M8) being compared. The p-value indicates the conﬁdence with which the
neutral model (M8a) can be rejected in favor of the model of positive selection (M8).
c dN/dS value of the dN/dS41 class of codons in M8, and the percent of codons falling in that class. na, not applicable.
d Codons assigned to the dN/dS41 class in M8 with a posterior probability of p40.90 by bayes empirical bayes analysis (np40.95, nnp40.99). Codon coordinates and
the encoded amino acid correspond to the human protein.
Fig. 3. ANKRD30A expression in humans. (A) A human tissue cDNA panel was probed for ANKDR30A expression using a primer set that spans an intron. As a positive control,
CRFK cells were engineered to stably express part of ANKRD30A. Human DNA was used to show the product size obtained from genomic template (with the intron). Because
ANKRD30A was originally identiﬁed as a gene associated with breast cancers, we also demonstrate its expression in a breast carcinoma line (HCC1937). (B) Expression of
ANKRD30Awas assessed in various laboratory cell lines. Cells were grown both with and without stimulation by 1000 U/ml interferon-β, and mRNAwas harvested. Expressed
and spliced transcripts were detected by RT-PCR. Primers were also designed to amplify spliced transcripts of NUP153 as a control for the amount of input material in each
reaction. (C) A summary of genome-wide screens for HIV host factors (Brass et al., 2008; Jäger et al., 2012; König et al., 2008; Yeung et al., 2009; Zhou et al., 2008), along with
relevant details of the methods used.
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role of ANKRD30B in HIV-1 biology. This could be quite important
because, in addition to having the strongest signature of positive
selection in our study, ANKRD30A is one of the few candidate HIV
host factors that has been categorized as a “druggable” target,
based on properties that it shares with proteins that have been
already successfully targeted by drugs (Bushman et al., 2009;
Hopkins and Groom, 2002).
In summary, a subset of HIV host factor genes is driven to
evolve under positive selection just like restriction factor genes are
known to be. Evolutionary studies should be useful in the func-
tional characterization of these host factors just as they have been
in the characterization of restriction factors.
Materials and methods
Primate biomaterials used
Primary and immortalized cell lines from various primate species
(see Fig. S1 in Supplemental material) were grown in standard media
supplemented with 15% fetal bovine serum at 37 1C and in 5% CO2.
Macaque, owl monkey, and squirrel monkey samples included in the
population study are listed in Supplemental Fig. S2, and were
acquired from either the Michale E Keeling Center for Comparative
Medicine and Research (Bastrop, Texas), or from the New England
Primate Research Center (Southborough, MA). For these individuals,
2.5 mL of whole blood was collected in PaxGene Blood RNA Tubes
(BD, #762165). Alternately, B cell lines were expanded in suspension
culture, in RPMI, 20% FBS, Pen/Strep, L-glutamine, HEPES, and AZT.
Genomic DNA and RNA from primate blood and cell lines were
isolated using the PaxGene miRNA kit (Qiagen, #763134) and/or the
Qiagen All Prep DNA/RNA mini kit (Qiagen, #80204).
Primate gene sequences
The method of acquisition for all primate gene sequences is
summarized in Fig. S3 found in Supplemental material. Human
Refseq sequences were obtained from the NCBI “gene” database.
Some chimpanzee, orangutan, rhesus macaque, and marmoset
gene sequences were obtained from the UCSC genome database
(http://genome.ucsc.edu/) using the BLAT alignment tool. Genes
were sequenced from 15 additional primate species and from
chimpanzee, orangutan, rhesus and marmoset in instances where
the genome-project sequences were of poor quality. PCR or RT-PCR
was performed from total RNA, gDNA, or cDNAwith SuperScript III
One-Step RT-PCR system with Platinum Taq (Invitrogen, #12574-
018), PCR SuperMix High Fidelity (Invitrogen, #10790-020), or
Phusion High Fidelity PCR Master Mix (NEB, #F-531S). Details of
the PCR and Sanger sequencing strategy, along with primer
sequences, are given in Table S1 found in Supplemental material.
Primate gene sequences have been deposited in GenBank (acces-
sion numbers KJ531711–KJ531825). Macaque, owl monkey, and
squirrel monkey population data (species and sampling scheme
summarized in Fig. S2 found in Supplemental material) were
acquired using primers listed in Table S1 found in Supplemental
material.
Human polymorphism analysis
Human SNPs were identiﬁed in datasets deposited by the 1000
Genomes Project (http://browser.1000genomes.org, release 13)
and NCBI's dbSNP database (http://www.ncbi.nlm.nih.gov/SNP).
Sliding window analysis
Sliding-window dN/dS calculations for each alignment were
performed with the SLIDERKK program (Parmley and Hurst, 2007).
Human–orangutan, human–rhesus and rhesus–marmoset alignments
were analyzed with standard window sizes (Demogines et al., 2010)
of 450 bp, 306 bp and 153 bp, respectively, to reﬂect the increasing
level of divergence in these species pairs (window size must be a
multiple of nine in this program). In order to generate conﬁdence
values for windows with dN/dS41, the K-estimator program
(Comeron, 1999) was utilized to generate a null distribution of
dN/dS values through Monte Carlo simulation in the gene region of
interest.
PAML analysis
Codon models were tested with codeml in the PAML 4.1 software
package (Yang, 1997). To detect selection, multiple alignments were
ﬁt to the NSsites models M8a (neutral model, codon values of dN/dS
ﬁt to a beta distribution plus an extra codon class ﬁxed at dN/dS¼1)
and M8 (positive selection model, similar to M8a but with the extra
class allowed to be dN/dS41). A likelihood ratio test was performed
to assess whether permitting codons to evolve under positive
selection gives a signiﬁcantly better ﬁt to the data (model compar-
ison M8a vs. M8). In situations where the neutral model could be
rejected (po0.05), posterior probabilities were assigned to indivi-
dual codons belonging to the class of codons with dN/dS41. For the
whole-gene dN/dS values indicated on the genome-wide distribution
of human/chimpanzee/rhesus gene trios, dN/dS values were calcu-
lated using the M0 model in PAML.
Expression analysis of ANKRD30A in human tissues and laboratory
cell lines
Primers were designed to amplify a 750 bp fragment that spans
the last two exons of ANKRD30A. PCR reactions were carried out
with PCR SuperMix High Fidelity (Invitrogen, #10790-020) along
with primers NRM602 (forward: 5'-TTAGGGAAGAATTAGGAA-
GAATC-3') and NRM604 (reverse: 5'-CATTTGACACTGTGTTT-
CACGTTG-3'). The Human Total RNA Master Panel II (Clontech,
#636643) was converted to cDNA using the SuperScript III First-
Strand Synthesis System (Invitrogen, #18080-051) and used as a
template in PCR reactions. The Human MTC cDNA Panel II
(Clontech, #636743) was also utilized. HeLa, 293T, Jurkat, and
breast carcinoma (HCC1937) cells were grown in standard media
and RNA was harvested using an All Prep DNA/RNA mini kit
(Qiagen, #80204). Each of these cell lines was also treated with
IFN-β (Betaseron) at a concentration of 1000 units/ml for 24 h
prior to isolation of RNA. ANKRD30A transcripts detected were
veriﬁed via sequencing.
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